UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.  )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

Payment of Filing Fee (Check all boxes that apply):

2025 TI T AN PHARMACEUTICALS, INC. Signature Signature, if held jointly Date , 2025. Pleas e sig n exactl y a s you r nam e appear s belo w . Whe n share s ar e hel d b y join t tenants , eac h shoul d sign . Whe n signin g a s attorne y , executo r, administrato r, trustee, guardian , corporat e o f fice r , o r partne r, pleas e giv e ful l titl e a s such. Please mark your votes lik e this X 19730 2 T ita n Pharma Proxy Car d Rev 3 Front CONTRO L NUMBER PROXY TH E BOAR D O F DIREC T OR S RECOMMEND S A VOT E FO R PROPOSAL S 1 , 2 , 3 , 4 AN D 5 , AN D FO R “ TW O YEAR S ” A S TH E FREQUENC Y FO R WHIC H S T OCKHOLDER S WIL L H A V E A VOT E O N EXECUTIV E COMPENS A TIO N . 4 . R A TIFIC A TION OF ENROME LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUN T ANT S FOR THE FISCAL YEAR ENDING DECEMBE R 31 , 2025. 5 . APPRO V A L OF OUR EXECUTIVE COMPENS A TION (S A Y - ON - P A Y). 6 . FREQUENCY OF S A Y - ON - P A Y VOTE. FOL D HER E • D O NO T SE P AR A T E • INSER T I N ENVELOP E PROVIDE D PLEAS E MARK , SIGN , D A T E AN D RETUR N TH E PROXY CAR D PROMPT L Y USIN G TH E ENCLOSE D ENVELOP E . a s if yo u marked , signe d an d returne d you r proxy card . V otes submitte d electronicall y over the Internet mus t be receive d by 1 1 : 5 9 p . m . , Eastern T ime, on Jun e 15 , 2025 . INTERNET ww w .cstproxyvote.com Us e the Internet to vote your prox y . Hav e your prox y card availabl e when you acces s the abov e website . Follow the prompt s to vote your shares. MOBILE VOTING On your Smartphone / T ablet , ope n the QR Reade r an d scan the belo w image. Once the voting site i s displayed , enter your Contro l Numbe r from the proxy card an d vote your shares. MAIL – Mark, sign an d dat e your proxy card an d return i t i n the postage - paid envelop e provided. ELECTION OF DIREC T ORS 1. APPRO V A L O F TH E 2015 PLAN AMENDMEN T . 3. V ot e b y Internet , Smartphon e o r T able t - QUIC K EAS Y IMMEDI A T E - 2 4 Hour s a Da y , 7 Day s a W ee k o r b y Mail Y our Mobile or Internet vot e authorize s the named proxies to vot e you r share s in the sam e manner Nominees: A vraham Ben - Tzvi Brynner Chiam Francisco Osvaldo Flores Garcia Firdauz Edmin Bin Mokhtar Gabriel Loh FOR al l nominees liste d a t lef t (except a s marked to the contrary below) WITHHOLD AUTHORITY to vote for al l nominees liste d a t left INSTRUCTION : T o withhol d authorit y t o vot e fo r an y nominee, writ e th e nominee ’ s nam e i n th e spac e provide d belo w . PLEASE D O NO T RETUR N THE PROXY CARD IF YOU AR E VOTING ELECTRONICAL L Y . YOUR VOTE IS IMPOR T AN T . PLEASE VOTE T OD A Y . FOR AGAINST ABS T AIN FOR AGAINST ABS T AIN FOR AGAINS T ABS T AIN FOR AGAINS T ABS T AIN EVE R Y ONE YEAR EVE R Y TWO YEARS EVE R Y THREE YEARS ABS T AIN APPRO V A L O F TH E ISSUANCE PROPOSA L . 2.

2025 FOL D HER E • D O NO T SE P AR A T E • INSER T I N ENVELOP E PROVIDE D THIS PROXY IS SOLICITED ON BEHAL F OF THE BOAR D OF DIREC T ORS PROXY FOR THE ANNUA L MEETING OF S T OCKHOLDERS OF TI T A N PHARMACEUTICALS, INC. T O B E HEL D ON JUN E 16 , 2025 The undersigne d appoint s Cha y W ee i Jye an d Brynner Chiam , an d eac h o f them, attorney s and agent s wit h full powe r o f substitution, i s hereb y authorize d to vote al l o f the shares o f common stock o f T ita n Pharmaceuticals, Inc . (the “Company”) whic h the undersigne d woul d b e entitle d to vote, if personall y present , a t the upcomin g Annual Meeting o f Stockholders o f the Compan y scheduled to be held at the offices of Olshan Frome W olosky LL P , located at 1325 A venue of the Americas, 15 th Floo r , New Y ork, New Y ork 10019 on Monda y , June 16 , 2025 at 9 : 00 a . m . (EST) (including any adjournments o r postponement s thereof an d an y meeting called i n lie u thereof, the “Annual Meeting”) . The und ersigned hereb y revokes an y prox y o r proxie s heretofor e give n an d acknowledge s receipt o f a copy o f the Notic e o f Meeting an d Proxy Statement an d a copy o f the Company ’ s Annual Repor t on Form 10 - K (without exhibits) for the fiscal year ended December 31 , 2024 . IF N O DIRECTIO N IS INDIC A TED WITH RESPEC T T O THE PROPOSALS ON THE REVERSE , THIS PROXY WILL B E VOTED “FOR AL L NOMINEES ” WITH RESPEC T T O PROPOSAL 1 AN D “FOR” PROPOSALS 2 , 3 , 4 AN D 5 AN D FOR “EVE R Y TWO YEARS” A S THE FREQUENCY FOR WHICH S T OCKHOLDERS WILL H A VE A VOTE ON EXECUTIVE COMPENS A TION . IMPOR T AN T : PLEASE SIGN, D A TE AN D MAIL THIS PROXY CAR D PROMPT L Y! CONTINUE D AN D T O B E SIGNED ON REVERS E SIDE 19730 2 T ita n Pharma Proxy Car d Rev 3 Back Important Notic e Regardin g the A vailabilit y of Proxy Materials for the Annua l Meeting of Stockholders Of T itan Pharmaceuticals, Inc. to be held on Jun e 16 , 2025 The proxy statemen t is availabl e at https://ww w .cstprox y .com/titanpharm/am2025